Retatrutide
Retatrutide is an investigational triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. It is being studied in Phase 3 trials by Eli Lilly for metabolic research endpoints including body weight and glycemic parameters.
Also known as: LY3437943, Triple G
Technical information
Molecular weight
4731.3 g/mol
Half-life
~6 days (subcutaneous)
Sequence
Modified 39-amino acid peptide (GLP-1/GIP/glucagon triple agonist)
Common research doses
1-12 mg weekly (research protocols)
Research areas
For research purposes only. PepAssure provides vendor information as a verification service and does not endorse or recommend any specific use. Consult qualified research protocols and institutional review boards.
Best Verified Vendors for Retatrutide
Ranked by PVS score — independent verification, no paid placements.
Canada · 99.4% reported purity · 130+ CoAs
USA · 99.2% reported purity · 97+ CoAs
USA · 99.2% reported purity · 97+ CoAs
USA · 99.1% reported purity · 137+ CoAs
USA · — reported purity · 25+ CoAs
USA · — reported purity · 26+ CoAs
Competitive landscape
Multi-signal comparison of every verified vendor selling Retatrutide — PVS, purity, CoA cadence, sentiment, and 30-day momentum.
Market overview
Aggregate signals across vendors selling Retatrutide
Side-by-side comparison
All verified vendors selling Retatrutide. Click a column header to sort. ★ marks the leader on that column.
| Vendor | PVS | Purity | CoAs | Sentiment | 30d Δ | Lab | Price |
|---|---|---|---|---|---|---|---|
| 1Ascension Peptides | ★93 | — | ★0 | ★92 | — | Janoshik | $$$ |
| 2Pure Rawz | 85 | — | ★0 | 86 | — | Janoshik | $ |
| 3Loti Labs | 85 | — | ★0 | 84 | — | Janoshik | $ |
| 4Chemical Planet | 80 | — | ★0 | 81 | — | Janoshik | $$ |
| 5Alder Bio Labs USA Made | 0 | — | ★0 | 0 | — | Janoshik | $$$ |
| 6Peptiva Research Labs | 0 | — | ★0 | 0 | — | Janoshik | $$$ |
Pillar leaders
Top-scoring vendor on each of the five PVS pillars
Recent purity track record
Approved community CoAs for Retatrutide, newest first